JAHA:亚裔美国人群心血管疾病负担的异质性研究

2019-03-21 不详 MedSci原创

亚裔美国人(印度、中国、菲律宾、韩国、日本和越南)的心血管疾病死亡模式差异很大,尤其在年轻人。本研究的目的旨在比较和评估亚裔美国人和非西班牙裔白人因缺血性心脏病和脑血管疾病而损失的潜在生命。本研究纳入了2003-2012年因各种原因死亡的人群,分析结果显示亚裔美国人在心血管疾病负担方面表现出异质性。其中印度裔的缺血性心脏病负担更高,印度裔男性2012年每100000人群中的损伤寿命为724年,因缺

亚裔美国人(印度、中国、菲律宾、韩国、日本和越南)的血管疾病死亡模式差异很大,尤其在年轻人。本研究的目的旨在比较和评估亚裔美国人和非西班牙裔白人因缺血性心脏病和脑血管疾病而损失的潜在生命。

本研究纳入了2003-2012年因各种原因死亡的人群,分析结果显示亚裔美国人在心血管疾病负担方面表现出异质性。其中印度裔的缺血性心脏病负担更高,印度裔男性2012年每100000人群中的损伤寿命为724年,因缺血性心脏病损伤的平均为17年。越南和菲律宾裔因脑血管疾病损伤的平均寿命分别为17和16年。另外,与非西班牙裔白人相比,所有亚裔人群的因脑血管损失的寿命均更多。

研究结果显示,亚裔美国人群的心血管疾病负担有较大的异质性,其中印度裔和菲律宾裔因缺血性心脏病死亡的最多,越南和菲律宾裔因脑血管死亡的最多。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1676114, encodeId=0def16e611456, content=<a href='/topic/show?id=10a692366f0' target=_blank style='color:#2F92EE;'>#质性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92366, encryptionId=10a692366f0, topicName=质性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aec27331343, createdName=fengxx, createdTime=Sun Jul 21 18:54:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910812, encodeId=b29e1910812e8, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jul 18 01:54:00 CST 2019, time=2019-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807339, encodeId=76e7180e339eb, content=<a href='/topic/show?id=6da2e97311c' target=_blank style='color:#2F92EE;'>#美国人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79731, encryptionId=6da2e97311c, topicName=美国人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sat Sep 14 07:54:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704574, encodeId=5aa21e04574f1, content=<a href='/topic/show?id=c4b72431520' target=_blank style='color:#2F92EE;'>#亚裔美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24315, encryptionId=c4b72431520, topicName=亚裔美国人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e530763703, createdName=lanyan20020096, createdTime=Mon Dec 23 21:54:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268098, encodeId=a4f2126809864, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333608, encodeId=ca931333608c1, content=<a href='/topic/show?id=1a1de07305e' target=_blank style='color:#2F92EE;'>#疾病负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70730, encryptionId=1a1de07305e, topicName=疾病负担)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B389FA68ECBF51BE2FE14093CF61F6AE/100, createdBy=eb8e2500096, createdName=夏天与十三菇凉, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498546, encodeId=839514985463a, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1676114, encodeId=0def16e611456, content=<a href='/topic/show?id=10a692366f0' target=_blank style='color:#2F92EE;'>#质性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92366, encryptionId=10a692366f0, topicName=质性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aec27331343, createdName=fengxx, createdTime=Sun Jul 21 18:54:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910812, encodeId=b29e1910812e8, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jul 18 01:54:00 CST 2019, time=2019-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807339, encodeId=76e7180e339eb, content=<a href='/topic/show?id=6da2e97311c' target=_blank style='color:#2F92EE;'>#美国人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79731, encryptionId=6da2e97311c, topicName=美国人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sat Sep 14 07:54:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704574, encodeId=5aa21e04574f1, content=<a href='/topic/show?id=c4b72431520' target=_blank style='color:#2F92EE;'>#亚裔美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24315, encryptionId=c4b72431520, topicName=亚裔美国人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e530763703, createdName=lanyan20020096, createdTime=Mon Dec 23 21:54:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268098, encodeId=a4f2126809864, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333608, encodeId=ca931333608c1, content=<a href='/topic/show?id=1a1de07305e' target=_blank style='color:#2F92EE;'>#疾病负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70730, encryptionId=1a1de07305e, topicName=疾病负担)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B389FA68ECBF51BE2FE14093CF61F6AE/100, createdBy=eb8e2500096, createdName=夏天与十三菇凉, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498546, encodeId=839514985463a, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1676114, encodeId=0def16e611456, content=<a href='/topic/show?id=10a692366f0' target=_blank style='color:#2F92EE;'>#质性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92366, encryptionId=10a692366f0, topicName=质性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aec27331343, createdName=fengxx, createdTime=Sun Jul 21 18:54:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910812, encodeId=b29e1910812e8, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jul 18 01:54:00 CST 2019, time=2019-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807339, encodeId=76e7180e339eb, content=<a href='/topic/show?id=6da2e97311c' target=_blank style='color:#2F92EE;'>#美国人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79731, encryptionId=6da2e97311c, topicName=美国人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sat Sep 14 07:54:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704574, encodeId=5aa21e04574f1, content=<a href='/topic/show?id=c4b72431520' target=_blank style='color:#2F92EE;'>#亚裔美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24315, encryptionId=c4b72431520, topicName=亚裔美国人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e530763703, createdName=lanyan20020096, createdTime=Mon Dec 23 21:54:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268098, encodeId=a4f2126809864, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333608, encodeId=ca931333608c1, content=<a href='/topic/show?id=1a1de07305e' target=_blank style='color:#2F92EE;'>#疾病负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70730, encryptionId=1a1de07305e, topicName=疾病负担)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B389FA68ECBF51BE2FE14093CF61F6AE/100, createdBy=eb8e2500096, createdName=夏天与十三菇凉, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498546, encodeId=839514985463a, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1676114, encodeId=0def16e611456, content=<a href='/topic/show?id=10a692366f0' target=_blank style='color:#2F92EE;'>#质性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92366, encryptionId=10a692366f0, topicName=质性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aec27331343, createdName=fengxx, createdTime=Sun Jul 21 18:54:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910812, encodeId=b29e1910812e8, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jul 18 01:54:00 CST 2019, time=2019-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807339, encodeId=76e7180e339eb, content=<a href='/topic/show?id=6da2e97311c' target=_blank style='color:#2F92EE;'>#美国人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79731, encryptionId=6da2e97311c, topicName=美国人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sat Sep 14 07:54:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704574, encodeId=5aa21e04574f1, content=<a href='/topic/show?id=c4b72431520' target=_blank style='color:#2F92EE;'>#亚裔美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24315, encryptionId=c4b72431520, topicName=亚裔美国人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e530763703, createdName=lanyan20020096, createdTime=Mon Dec 23 21:54:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268098, encodeId=a4f2126809864, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333608, encodeId=ca931333608c1, content=<a href='/topic/show?id=1a1de07305e' target=_blank style='color:#2F92EE;'>#疾病负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70730, encryptionId=1a1de07305e, topicName=疾病负担)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B389FA68ECBF51BE2FE14093CF61F6AE/100, createdBy=eb8e2500096, createdName=夏天与十三菇凉, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498546, encodeId=839514985463a, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1676114, encodeId=0def16e611456, content=<a href='/topic/show?id=10a692366f0' target=_blank style='color:#2F92EE;'>#质性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92366, encryptionId=10a692366f0, topicName=质性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aec27331343, createdName=fengxx, createdTime=Sun Jul 21 18:54:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910812, encodeId=b29e1910812e8, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jul 18 01:54:00 CST 2019, time=2019-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807339, encodeId=76e7180e339eb, content=<a href='/topic/show?id=6da2e97311c' target=_blank style='color:#2F92EE;'>#美国人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79731, encryptionId=6da2e97311c, topicName=美国人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sat Sep 14 07:54:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704574, encodeId=5aa21e04574f1, content=<a href='/topic/show?id=c4b72431520' target=_blank style='color:#2F92EE;'>#亚裔美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24315, encryptionId=c4b72431520, topicName=亚裔美国人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e530763703, createdName=lanyan20020096, createdTime=Mon Dec 23 21:54:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268098, encodeId=a4f2126809864, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333608, encodeId=ca931333608c1, content=<a href='/topic/show?id=1a1de07305e' target=_blank style='color:#2F92EE;'>#疾病负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70730, encryptionId=1a1de07305e, topicName=疾病负担)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B389FA68ECBF51BE2FE14093CF61F6AE/100, createdBy=eb8e2500096, createdName=夏天与十三菇凉, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498546, encodeId=839514985463a, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=)]
    2019-03-23 zhaohui6731
  6. [GetPortalCommentsPageByObjectIdResponse(id=1676114, encodeId=0def16e611456, content=<a href='/topic/show?id=10a692366f0' target=_blank style='color:#2F92EE;'>#质性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92366, encryptionId=10a692366f0, topicName=质性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aec27331343, createdName=fengxx, createdTime=Sun Jul 21 18:54:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910812, encodeId=b29e1910812e8, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jul 18 01:54:00 CST 2019, time=2019-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807339, encodeId=76e7180e339eb, content=<a href='/topic/show?id=6da2e97311c' target=_blank style='color:#2F92EE;'>#美国人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79731, encryptionId=6da2e97311c, topicName=美国人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sat Sep 14 07:54:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704574, encodeId=5aa21e04574f1, content=<a href='/topic/show?id=c4b72431520' target=_blank style='color:#2F92EE;'>#亚裔美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24315, encryptionId=c4b72431520, topicName=亚裔美国人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e530763703, createdName=lanyan20020096, createdTime=Mon Dec 23 21:54:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268098, encodeId=a4f2126809864, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333608, encodeId=ca931333608c1, content=<a href='/topic/show?id=1a1de07305e' target=_blank style='color:#2F92EE;'>#疾病负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70730, encryptionId=1a1de07305e, topicName=疾病负担)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B389FA68ECBF51BE2FE14093CF61F6AE/100, createdBy=eb8e2500096, createdName=夏天与十三菇凉, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498546, encodeId=839514985463a, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1676114, encodeId=0def16e611456, content=<a href='/topic/show?id=10a692366f0' target=_blank style='color:#2F92EE;'>#质性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92366, encryptionId=10a692366f0, topicName=质性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0aec27331343, createdName=fengxx, createdTime=Sun Jul 21 18:54:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910812, encodeId=b29e1910812e8, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Jul 18 01:54:00 CST 2019, time=2019-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807339, encodeId=76e7180e339eb, content=<a href='/topic/show?id=6da2e97311c' target=_blank style='color:#2F92EE;'>#美国人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79731, encryptionId=6da2e97311c, topicName=美国人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sat Sep 14 07:54:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704574, encodeId=5aa21e04574f1, content=<a href='/topic/show?id=c4b72431520' target=_blank style='color:#2F92EE;'>#亚裔美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24315, encryptionId=c4b72431520, topicName=亚裔美国人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e530763703, createdName=lanyan20020096, createdTime=Mon Dec 23 21:54:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268098, encodeId=a4f2126809864, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333608, encodeId=ca931333608c1, content=<a href='/topic/show?id=1a1de07305e' target=_blank style='color:#2F92EE;'>#疾病负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70730, encryptionId=1a1de07305e, topicName=疾病负担)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B389FA68ECBF51BE2FE14093CF61F6AE/100, createdBy=eb8e2500096, createdName=夏天与十三菇凉, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498546, encodeId=839514985463a, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Sat Mar 23 04:54:00 CST 2019, time=2019-03-23, status=1, ipAttribution=)]

相关资讯

JACC:直接口服抗凝药物对二尖瓣狭窄患者的影响

对于二尖瓣狭窄和房颤患者,需要服用抗凝药物以预防卒中的发生,到目前为止,所有研究直接口服抗凝药物(DOACs)的研究均排除了中重度二尖瓣狭窄患者。本研究的目的旨在评估DOACs对二尖瓣狭窄患者的疗效影响。本研究纳入了2230名二尖瓣狭窄和房颤患者(平均年龄为69.7±10.5岁,男性占30.6%),主要终点事件是缺血性卒中或系统性血栓的发生。结果显示,血栓栓塞事件的发生率在DOAC组中为2.22%

JACC:医保政策对心衰患者再住院率的影响

医疗保险医院减少再入院计划导致主要诊断为心力衰竭(HF)的住院后再入院人数减少,且心衰患者很少因为其他原因再住院。本研究旨在比较主要心衰住院和其他心衰住院后经医疗保险风险调整的30天再入院的趋势。本研究纳入了2008-2015年12973853名主要或次要因为心衰住院的医保患者,住院患者分为以下几类:主要因心衰住院的,主要急性心肌梗死或肺炎继发性心力衰竭住院的,和其他原因继发心衰住院的。在2010

JACC:IL-1β对急性失代偿心衰患者预后的预测价值

可溶性ST2(sST2)是白介素(IL)-1受体样-1的一种形式,可以预测急性失代偿心衰(ADHF)的风险。 IL-1β是一个对心肌重塑和功能有害的炎症因子,急性心梗后 IL-1β抑制剂的应用可以改善预后,然而, IL-1β与ADHF和sST2的相关性尚不明确。本研究的目的旨在评估IL-1β与sST2的相关性,及其对ADHF患者的预后价值。本研究纳入了316名因ADHF住院的患者(平均年龄为72±

盘点:JACC三月第二期研究一览

1.房颤患者认知功能的降低与亚临床脑损伤相关DOI: 10.1016/j.jacc.2018.12.039http://www.onlinejacc.org/content/73/9房颤患者发生认知功能下降的风险更高,可能是由未知的脑血管损伤引起。本研究的目的旨在评估房颤患者的认知功能和脑血管损伤的相关性。本研究纳入了1737名房颤患者,平均年龄为73 ± 8 岁,女性占28%,90%接受有口服抗

BMJ:盐摄入与心血管事件及死亡风险

研究发现,极少数人的日常饮食符合WHO推荐的高钾低钠饮食,高钾及中度钠摄入(3-5g/天)人群的与死亡和心血管事件风险最低

JAMA:现行心血管疾病临床指南证据等级研究

研究发现,现行心血管疾病临床治疗指南中,仅少部分的推荐方案是依据多个或大型临床研究结论制定的,这一现象在近10年间无显著改善